Recent Updates
Recently added Catalysts
ODTX Positive Sentiment

Odyssey Therapeutics to Participate in Upcoming Investor Conferences

Key Takeaway: Odyssey Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in several upcoming investor conferences in September 2026. These events include the Cantor Global Healthcare Conference, the Morgan Stanley Global Healthcare Conference, and the H.C. Wainwright Global Investment Conference. The company aims to showcase its innovative approach to treating autoimmune and inflammatory diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • Odyssey Therapeutics is actively participating in multiple investor conferences.
  • The company aims to transform care for autoimmune and inflammatory diseases.
  • Odyssey has a promising portfolio of medicines in development.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~37 mo
Minimal dilution risk
Lead asset
OD-07656
Phase 2 · Ulcerative Colitis (UC)

Full Press Release Details

BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology, today announced that members of its management team will participate in the following upcoming investor conferences in September:
• 2026 Cantor Global Healthcare Conference Conference Dates: September 9-11, 2026 Location: New York, NY Fireside Chat: September 9 th at 8:35AM ET
• Morgan Stanley 24th Annual Global Healthcare Conference Conference Dates: September 14-16, 2026 Location: New York, NY Fireside Chat: September 14 th at 10:45AM ET
• H.C. Wainwright 28th Annual Global Investment Conference Conference Dates: September 14-16, 2026 Location: New York, NY Fireside Chat: September 15 th at 1:00PM ET
Where available, live webcasts will be available under “News and Events” in the Investors section of the Company’s website at www.odysseytx.com. Replays of the webcasts will be made available on the Events page of Odyssey’s investor website and archived for 60 days.

About Odyssey Therapeutics

Odyssey Therapeutics is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology. Since its founding in 2021, Odyssey has built a portfolio of internally discovered and developed medicines with its first program advancing through multiple clinical milestones. Odyssey’s portfolio leverages the scientific expertise of its team of experienced drug hunters and a comprehensive suite of tools to efficiently advance product candidates that the Company believes have the potential to induce deep and durable remission for patients across several inflammatory diseases with unmet need.
For more information, please visit https://odysseytx.com/ and follow Odyssey on LinkedIn or X.

Investor Relations Collin Todd SVP, Strategy and Business Development investors@odysseytx.com

Frequently Asked Questions

What conferences will Odyssey Therapeutics attend?

Odyssey Therapeutics will attend the Cantor Global Healthcare Conference, Morgan Stanley Global Healthcare Conference, and H.C. Wainwright Global Investment Conference.

When is the Cantor Global Healthcare Conference?

The Cantor Global Healthcare Conference is scheduled for September 9-11, 2026.

What is the focus of Odyssey Therapeutics?

Odyssey Therapeutics focuses on developing medicines for autoimmune and inflammatory diseases.

Where can I watch the conference webcasts?

Live webcasts will be available on Odyssey's investor website under 'News and Events.'

Last updated: Aug 26, 2026